董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Makarand Jawadekar | 男 | Independent Director | 72 | 4.00万美元 | 未持股 | 2023-11-13 |
| Theodore Edward Rokita | 男 | Independent Director | 53 | 4.00万美元 | 未持股 | 2023-11-13 |
| Brian Zucker | 男 | Independent Director | 61 | 4.00万美元 | 未持股 | 2023-11-13 |
| Anil Diwan | 男 | President, Chairman of the Board, Chief Executive Officer | 65 | 44.37万美元 | 200.54 | 2023-11-13 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Anil Diwan | 男 | President, Chairman of the Board, Chief Executive Officer | 65 | 44.37万美元 | 200.54 | 2023-11-13 |
| Meeta Vyas | 女 | Chief Financial Officer | 64 | 13.73万美元 | 14.70 | 2023-11-13 |
董事简历
中英对照 | 中文 | 英文- Makarand Jawadekar
-
Makarand Jawadekar在制药行业拥有超过35年的经验，涉及商业和研究活动。Jawadekar博士在合资企业、联盟管理、承包、外包、基准测试、绩效指标、制药研究与开发、药物输送技术、配方、临床供应制造和包装、临床试验材料、制药和药物科学等方面有着丰富的经验。他也拥有在美国、欧洲、印度和亚洲其他地区（包括日本和中国）工作的深厚知识和全球经验。在他的职业生涯中，他帮助创建了几个制药研发伙伴关系、合资企业和协作。
Makarand Jawadekar,has served as an independent Director of the Company since February2020. He has over 35 years of experience in the pharma industry spanning both business and research activities. Dr.Jawadekar has extensive experience in joint ventures, alliance management, contracting, outsourcing, benchmarking, performance metrics, pharmaceutical research and development, drug delivery technologies, formulations, clinical supply manufacturing and packaging, clinical trial materials, pharmaceutics, and pharmaceutical sciences. He also has deep knowledge and global experience working across the United States, Europe,India, and other parts of Asia, including Japan and China. He has helped create several pharma R&D partnerships, joint ventures, and collaborations during his career. - Makarand Jawadekar在制药行业拥有超过35年的经验，涉及商业和研究活动。Jawadekar博士在合资企业、联盟管理、承包、外包、基准测试、绩效指标、制药研究与开发、药物输送技术、配方、临床供应制造和包装、临床试验材料、制药和药物科学等方面有着丰富的经验。他也拥有在美国、欧洲、印度和亚洲其他地区（包括日本和中国）工作的深厚知识和全球经验。在他的职业生涯中，他帮助创建了几个制药研发伙伴关系、合资企业和协作。
- Makarand Jawadekar,has served as an independent Director of the Company since February2020. He has over 35 years of experience in the pharma industry spanning both business and research activities. Dr.Jawadekar has extensive experience in joint ventures, alliance management, contracting, outsourcing, benchmarking, performance metrics, pharmaceutical research and development, drug delivery technologies, formulations, clinical supply manufacturing and packaging, clinical trial materials, pharmaceutics, and pharmaceutical sciences. He also has deep knowledge and global experience working across the United States, Europe,India, and other parts of Asia, including Japan and China. He has helped create several pharma R&D partnerships, joint ventures, and collaborations during his career.
- Theodore Edward Rokita
-
Theodore Edward Rokita目前担任Apex Benefits Group，Inc.外部事务and General Counsel和Vice President，在那里他担任执行团队和公司董事会成员。他负责法律策略，包括诉讼、收购和其他事务，主要涉及ERISA和就业法，并负责Apex’；s客户的法规遵从性。在他的角色中，他担任ApexBG的公众形象，并负责外部消息传递、事件和其他外联功能。Rokita先生作为印第安纳州的代表当选为美国国会议员，从2011年至2019年任期四届。作为美国国会议员，他曾担任众议院幼儿、小学和中学教育小组委员会主席，众议院预算委员会副主席，众议院教育委员会和劳动力健康、就业、劳工和养老金小组委员会成员，众议院运输和基础设施委员会，航空，铁路和管道小组委员会），众议院行政委员会成员（2011年至2014年），指导委员会成员（2011年至2012年）（由同行选举产生，以完成其委员会任务），还担任共和党研究委员会主任（2014年至2019年）（影响政策方向和策略的小组）。在此之前，Rokita先生曾担任印第安纳州国务卿（2003年至2011年），并于2000年至2002年担任印第安纳州国务卿办公室首席运营官and General Counsel。Rokita先生目前或曾经担任多家商业和慈善机构的董事会成员，其中包括:飞机所有者和飞行员协会基金会（2014年至今）；印第安纳波利斯Achieve International in（帮助问题青少年）（2012年至2018年）；圣文森特医院基金会（2011年至2013年）；印第安纳州经济教育委员会（2004年至2010年）。Rokita先生还担任或曾担任多个机构的顾问委员会成员，其中包括:Merchandise Warehouse，Inc.。印第安纳波利斯（2019年至今）；华沙Wishbone Medical，Inc.（2019年至今）；弗吉尼亚州雷斯顿Acel360Inc.咨询委员会成员（2019年至今）。Rokita先生还于2007年至2017年担任伦斯勒圣约瑟夫学院（Saint Joseph’；s College，Rensselaer）的董事会成员。除了他的公共服务，Rokita先生还是退伍军人空运司令部和Angel Flight的志愿者（2011年至今），积极执行退伍军人空运指挥部和其他类似非营利组织的飞行任务，致力于为儿童和9/11后战斗受伤退伍军人及其家属提供免费空运，用于医疗和其他同情目的。Rokita先生拥有印第安纳州克劳福兹维尔Wabash College的文学学士学位，在那里他是Eli Lilly Fellow和IUPUI印第安纳大学Robert H.McKinney法学院的法学博士。
Theodore Edward Rokita,has been an independent Director of NanoViricides,Inc. since May2020. Honorable Mr.Rokita currently serves as the Attorney General of the State of Indiana, a publicly elected position. He is also a co-owner of and was General Counsel and Vice President of External Affairs, of Apex Benefits Group,Inc. where he served as a member of the executive team and the corporate board. He was responsible for legal strategies, including litigation, acquisitions and other matters, primarily involving ERISA and employment laws, and was responsible for the regulatory compliance of Apex's clients. In his role, he served as the public face of Apex and was responsible for external messaging, events, and other outreach functions. Previously, Mr.Rokita was elected to the United States Congress as a Representative from the State of Indiana, serving four terms from 2011 to 2019. As a member of the US Congress, he served as the Chairman, House Subcommittee on Early Childhood, Elementary, and Secondary Education, as the Vice Chairman, House Committee on the Budget, as a Member, House Committee on Education and the Workforce (Health, Employment, Labor and Pensions subcommittee), as a Member, House Committee on Transportation and Infrastructure, (aviation, railroad, and pipeline subcommittees), as a Member, Committee on House Administration (2011-2014), as a Member, Steering Committee (2011-2012) (elected by peers to make their committee assignments), and also as a Director, Republican Study Committee (2014- 2019) (group affecting policy direction and tactics). Prior thereto Mr.Rokita served as the Secretary of State,Indiana, from 2003 to 2011 and as Chief Operating Officer and General Counsel, Office of Indiana Secretary of State from 2000-2002. Mr.Rokita serves or has served as a Member of the Board of Directors on a number of commercial and charitable institutions, among them: Aircraft Owners and Pilots Association Foundation, (2014-Present); Achieve International,Indianapolis,IN (helping troubled teens), (2012-2018); Saint Vincent Hospital Foundation, (2011-2013); Indiana Council for Economic Education, (2004-2010). Mr.Rokita also serves or has served as an Advisory Board Member for several institutions, among them: Merchandise Warehouse,Inc. Indianapolis,IN, (2019-Present); WishBone Medical,Inc., Warsaw,IN, (2019-Present); and Acel 360,Inc., Reston, VA, (2019-Present). Mr.Rokita has also served as a Member, Board of Trustees of Saint Joseph's College, Rensselaer,IN, (2007-2017). In addition to his public service, Mr.Rokita is involved as a Volunteer for the Veterans Airlift Command and Angel Flight, (2011- Present), actively flying missions for Veterans Airlift Command and other similar non-profits dedicated to providing free air transportation to children and post-9/11 combat wounded veterans and their families for medical and other compassionate purposes. Mr.Rokita holds a Bachelor of Arts degree from Wabash College in Crawfordsville,Indiana, where he was an Eli Lilly Fellow and a Juris Doctor from IUPUI's Indiana University Robert H. McKinney School of Law. - Theodore Edward Rokita目前担任Apex Benefits Group，Inc.外部事务and General Counsel和Vice President，在那里他担任执行团队和公司董事会成员。他负责法律策略，包括诉讼、收购和其他事务，主要涉及ERISA和就业法，并负责Apex’；s客户的法规遵从性。在他的角色中，他担任ApexBG的公众形象，并负责外部消息传递、事件和其他外联功能。Rokita先生作为印第安纳州的代表当选为美国国会议员，从2011年至2019年任期四届。作为美国国会议员，他曾担任众议院幼儿、小学和中学教育小组委员会主席，众议院预算委员会副主席，众议院教育委员会和劳动力健康、就业、劳工和养老金小组委员会成员，众议院运输和基础设施委员会，航空，铁路和管道小组委员会），众议院行政委员会成员（2011年至2014年），指导委员会成员（2011年至2012年）（由同行选举产生，以完成其委员会任务），还担任共和党研究委员会主任（2014年至2019年）（影响政策方向和策略的小组）。在此之前，Rokita先生曾担任印第安纳州国务卿（2003年至2011年），并于2000年至2002年担任印第安纳州国务卿办公室首席运营官and General Counsel。Rokita先生目前或曾经担任多家商业和慈善机构的董事会成员，其中包括:飞机所有者和飞行员协会基金会（2014年至今）；印第安纳波利斯Achieve International in（帮助问题青少年）（2012年至2018年）；圣文森特医院基金会（2011年至2013年）；印第安纳州经济教育委员会（2004年至2010年）。Rokita先生还担任或曾担任多个机构的顾问委员会成员，其中包括:Merchandise Warehouse，Inc.。印第安纳波利斯（2019年至今）；华沙Wishbone Medical，Inc.（2019年至今）；弗吉尼亚州雷斯顿Acel360Inc.咨询委员会成员（2019年至今）。Rokita先生还于2007年至2017年担任伦斯勒圣约瑟夫学院（Saint Joseph’；s College，Rensselaer）的董事会成员。除了他的公共服务，Rokita先生还是退伍军人空运司令部和Angel Flight的志愿者（2011年至今），积极执行退伍军人空运指挥部和其他类似非营利组织的飞行任务，致力于为儿童和9/11后战斗受伤退伍军人及其家属提供免费空运，用于医疗和其他同情目的。Rokita先生拥有印第安纳州克劳福兹维尔Wabash College的文学学士学位，在那里他是Eli Lilly Fellow和IUPUI印第安纳大学Robert H.McKinney法学院的法学博士。
- Theodore Edward Rokita,has been an independent Director of NanoViricides,Inc. since May2020. Honorable Mr.Rokita currently serves as the Attorney General of the State of Indiana, a publicly elected position. He is also a co-owner of and was General Counsel and Vice President of External Affairs, of Apex Benefits Group,Inc. where he served as a member of the executive team and the corporate board. He was responsible for legal strategies, including litigation, acquisitions and other matters, primarily involving ERISA and employment laws, and was responsible for the regulatory compliance of Apex's clients. In his role, he served as the public face of Apex and was responsible for external messaging, events, and other outreach functions. Previously, Mr.Rokita was elected to the United States Congress as a Representative from the State of Indiana, serving four terms from 2011 to 2019. As a member of the US Congress, he served as the Chairman, House Subcommittee on Early Childhood, Elementary, and Secondary Education, as the Vice Chairman, House Committee on the Budget, as a Member, House Committee on Education and the Workforce (Health, Employment, Labor and Pensions subcommittee), as a Member, House Committee on Transportation and Infrastructure, (aviation, railroad, and pipeline subcommittees), as a Member, Committee on House Administration (2011-2014), as a Member, Steering Committee (2011-2012) (elected by peers to make their committee assignments), and also as a Director, Republican Study Committee (2014- 2019) (group affecting policy direction and tactics). Prior thereto Mr.Rokita served as the Secretary of State,Indiana, from 2003 to 2011 and as Chief Operating Officer and General Counsel, Office of Indiana Secretary of State from 2000-2002. Mr.Rokita serves or has served as a Member of the Board of Directors on a number of commercial and charitable institutions, among them: Aircraft Owners and Pilots Association Foundation, (2014-Present); Achieve International,Indianapolis,IN (helping troubled teens), (2012-2018); Saint Vincent Hospital Foundation, (2011-2013); Indiana Council for Economic Education, (2004-2010). Mr.Rokita also serves or has served as an Advisory Board Member for several institutions, among them: Merchandise Warehouse,Inc. Indianapolis,IN, (2019-Present); WishBone Medical,Inc., Warsaw,IN, (2019-Present); and Acel 360,Inc., Reston, VA, (2019-Present). Mr.Rokita has also served as a Member, Board of Trustees of Saint Joseph's College, Rensselaer,IN, (2007-2017). In addition to his public service, Mr.Rokita is involved as a Volunteer for the Veterans Airlift Command and Angel Flight, (2011- Present), actively flying missions for Veterans Airlift Command and other similar non-profits dedicated to providing free air transportation to children and post-9/11 combat wounded veterans and their families for medical and other compassionate purposes. Mr.Rokita holds a Bachelor of Arts degree from Wabash College in Crawfordsville,Indiana, where he was an Eli Lilly Fellow and a Juris Doctor from IUPUI's Indiana University Robert H. McKinney School of Law.
- Brian Zucker
-
Brian Zucker，2011年10月起，担任CFO Financial Partners，LLC的合伙人，这是一家为公共和私人公司、经纪交易商、对冲基金提供外包CFO 首席财务官、财务总监和财务运营服务，以及后台报告和簿记服务的公司，家族理财室和高净值个人等等。Zucker先生还担任许多经纪交易商和对冲基金的首席财务官兼财务运营负责人。除此之外，Zucker先生还担任RRBB Accountants&Advisors，Aka Rosenberg Rich Baker Berman&Co.的合伙人，这是一家位于新泽西州中部的全方位服务的会计，咨询和咨询公司。Zucker先生在证券行业拥有超过30年的注册会计师经验。从1983年到1986年，Zucker先生是Deloitte Haskins and Sells和Price Waterhouse的高级顾问（从1987年1月到1989年9月）。他此前曾担任Atlantis Business Development Corp.的总裁兼主席、Natcore Solar Technology，Inc.的首席财务官，以及American Frontier Financial Corp.的董事总经理。他是国家投资银行协会的董事会成员。Zucker先生在佩斯大学获得公共会计学士学位。
Brian Zucker,has been an independent Director of NanoViricides,Inc. since November2020. Since October2011, Mr.Zucker has been a Partner at CFO Financial Partners, LLC, a firm that provides outsourced CFO (Chief Financial Officer), Controller and Financial Operations services as well as back office reporting and bookkeeping services for public and private companies, broker dealers, hedge funds, and family offices and high net worth individuals, among others. Mr.Zucker also serves as the CFO and Financial Operations Principal for numerous broker dealers and hedge funds. In addition to and simultaneously therewith, Mr.Zucker has served as a Partner at RRBB Accountants& Advisors, (aka Rosenberg Rich Baker Berman& Co.), a full-service accounting, advisory and consulting firm located in Central New Jersey. Mr.Zucker has over thirty years of experience as a CPA specializing in the securities industry. From 1983 through 1986, Mr.Zucker was a Senior Consultant at Deloitte Haskins and Sells and at Price Waterhouse from January1987 through September1989. He has previously served as the President and Chairman of Atlantis Business Development Corp. (ABDV), CFO of Natcore Solar Technology,Inc. (NTCXF) and as a Managing Director of American Frontier Financial Corp. (EVIS). Since May2018, he has been serving as the CFO of EIG Energy Partners Capital Markets, LLC. Brian holds a CPA in States of New Jersey and New York, and holds several FINRA licenses. He is on the Board of Directors of National Investment Banking Association (NIBA). Mr.Zucker obtained a B.S. in Public Accounting from Pace university. - Brian Zucker，2011年10月起，担任CFO Financial Partners，LLC的合伙人，这是一家为公共和私人公司、经纪交易商、对冲基金提供外包CFO 首席财务官、财务总监和财务运营服务，以及后台报告和簿记服务的公司，家族理财室和高净值个人等等。Zucker先生还担任许多经纪交易商和对冲基金的首席财务官兼财务运营负责人。除此之外，Zucker先生还担任RRBB Accountants&Advisors，Aka Rosenberg Rich Baker Berman&Co.的合伙人，这是一家位于新泽西州中部的全方位服务的会计，咨询和咨询公司。Zucker先生在证券行业拥有超过30年的注册会计师经验。从1983年到1986年，Zucker先生是Deloitte Haskins and Sells和Price Waterhouse的高级顾问（从1987年1月到1989年9月）。他此前曾担任Atlantis Business Development Corp.的总裁兼主席、Natcore Solar Technology，Inc.的首席财务官，以及American Frontier Financial Corp.的董事总经理。他是国家投资银行协会的董事会成员。Zucker先生在佩斯大学获得公共会计学士学位。
- Brian Zucker,has been an independent Director of NanoViricides,Inc. since November2020. Since October2011, Mr.Zucker has been a Partner at CFO Financial Partners, LLC, a firm that provides outsourced CFO (Chief Financial Officer), Controller and Financial Operations services as well as back office reporting and bookkeeping services for public and private companies, broker dealers, hedge funds, and family offices and high net worth individuals, among others. Mr.Zucker also serves as the CFO and Financial Operations Principal for numerous broker dealers and hedge funds. In addition to and simultaneously therewith, Mr.Zucker has served as a Partner at RRBB Accountants& Advisors, (aka Rosenberg Rich Baker Berman& Co.), a full-service accounting, advisory and consulting firm located in Central New Jersey. Mr.Zucker has over thirty years of experience as a CPA specializing in the securities industry. From 1983 through 1986, Mr.Zucker was a Senior Consultant at Deloitte Haskins and Sells and at Price Waterhouse from January1987 through September1989. He has previously served as the President and Chairman of Atlantis Business Development Corp. (ABDV), CFO of Natcore Solar Technology,Inc. (NTCXF) and as a Managing Director of American Frontier Financial Corp. (EVIS). Since May2018, he has been serving as the CFO of EIG Energy Partners Capital Markets, LLC. Brian holds a CPA in States of New Jersey and New York, and holds several FINRA licenses. He is on the Board of Directors of National Investment Banking Association (NIBA). Mr.Zucker obtained a B.S. in Public Accounting from Pace university.
- Anil Diwan
-
Anil Diwan自2005年6月1日NanoViricides完成合并以来，一直担任NanoViricides总裁兼董事会主席，2019年2月担任执行主席。Diwan博士自1995年起担任AllExcel公司首席执行官兼董事，2004年至今担任TheraCour制药公司首席执行官，并且是NanoViricides公司许可使用的技术的原始发明人，以及基于它们的TheraCour聚合物胶束技术和产品。自1992年起，他开始研究和开发TheraCour纳米材料。Diwan博士是最早提出开发用于药物递送的新型悬挂式聚合物的科学家之一，这导致了聚合物胶束的药理应用研究的爆炸式增长。Anil已经获得了超过12项NIH SBIR资助。Diwan博士拥有若干已发布的专利，以及在若干国家处于不同起诉阶段的五项PCT国际专利申请，并向专利代理人提交了若干其他可申请专利的发现的知识产权证明。Diwan博士曾获得多项学术荣誉，包括在所有IIT的联合入学考试中获得全印度第9名。他拥有美国莱斯大学生化工程博士学位-1986年和印度理工学院（IIT）孟买化学工程学士学位-1980年。
Anil Diwan,has been President and the Chairman of the Board of Directors of the Company since consummation of the merger on June 1, 2005. Dr. Diwan simultaneously therewith and since its formation, has also served as the Chief Executive Officer and Director of AllExcel, Inc. (from 1995 to the present) and TheraCour Pharma, Inc. (from 2004 to the present) and is the original inventor of the technologies licensed to NanoViricides Inc., as well as the TheraCour polymeric micelle technologies and products based on them. Since 1992, he has researched and developed TheraCour nanomaterials. Dr. Diwan was one of the first scientists to propose the development of novel pendant polymers for drug delivery that led to an explosion of research in pharmacological applications of polymeric micelles. Dr. Diwan has won over 12 NIH SBIR grants. Dr. Diwan holds several issued patents, and two recent PCT international patent applications in various stages of prosecution in a number of countries, and also has several additional patentable discoveries. Dr. Diwan has held several scholastic distinctions, including an All-India 9th rank on the Joint Entrance Examination of all IIT's. He holds a Ph.D. in Biochemical Engineering from Rice University (1986) and B.S. in Chemical Engineering from Indian Institute of Technology (IIT) Bombay (1980). - Anil Diwan自2005年6月1日NanoViricides完成合并以来，一直担任NanoViricides总裁兼董事会主席，2019年2月担任执行主席。Diwan博士自1995年起担任AllExcel公司首席执行官兼董事，2004年至今担任TheraCour制药公司首席执行官，并且是NanoViricides公司许可使用的技术的原始发明人，以及基于它们的TheraCour聚合物胶束技术和产品。自1992年起，他开始研究和开发TheraCour纳米材料。Diwan博士是最早提出开发用于药物递送的新型悬挂式聚合物的科学家之一，这导致了聚合物胶束的药理应用研究的爆炸式增长。Anil已经获得了超过12项NIH SBIR资助。Diwan博士拥有若干已发布的专利，以及在若干国家处于不同起诉阶段的五项PCT国际专利申请，并向专利代理人提交了若干其他可申请专利的发现的知识产权证明。Diwan博士曾获得多项学术荣誉，包括在所有IIT的联合入学考试中获得全印度第9名。他拥有美国莱斯大学生化工程博士学位-1986年和印度理工学院（IIT）孟买化学工程学士学位-1980年。
- Anil Diwan,has been President and the Chairman of the Board of Directors of the Company since consummation of the merger on June 1, 2005. Dr. Diwan simultaneously therewith and since its formation, has also served as the Chief Executive Officer and Director of AllExcel, Inc. (from 1995 to the present) and TheraCour Pharma, Inc. (from 2004 to the present) and is the original inventor of the technologies licensed to NanoViricides Inc., as well as the TheraCour polymeric micelle technologies and products based on them. Since 1992, he has researched and developed TheraCour nanomaterials. Dr. Diwan was one of the first scientists to propose the development of novel pendant polymers for drug delivery that led to an explosion of research in pharmacological applications of polymeric micelles. Dr. Diwan has won over 12 NIH SBIR grants. Dr. Diwan holds several issued patents, and two recent PCT international patent applications in various stages of prosecution in a number of countries, and also has several additional patentable discoveries. Dr. Diwan has held several scholastic distinctions, including an All-India 9th rank on the Joint Entrance Examination of all IIT's. He holds a Ph.D. in Biochemical Engineering from Rice University (1986) and B.S. in Chemical Engineering from Indian Institute of Technology (IIT) Bombay (1980).
高管简历
中英对照 | 中文 | 英文- Anil Diwan
Anil Diwan自2005年6月1日NanoViricides完成合并以来，一直担任NanoViricides总裁兼董事会主席，2019年2月担任执行主席。Diwan博士自1995年起担任AllExcel公司首席执行官兼董事，2004年至今担任TheraCour制药公司首席执行官，并且是NanoViricides公司许可使用的技术的原始发明人，以及基于它们的TheraCour聚合物胶束技术和产品。自1992年起，他开始研究和开发TheraCour纳米材料。Diwan博士是最早提出开发用于药物递送的新型悬挂式聚合物的科学家之一，这导致了聚合物胶束的药理应用研究的爆炸式增长。Anil已经获得了超过12项NIH SBIR资助。Diwan博士拥有若干已发布的专利，以及在若干国家处于不同起诉阶段的五项PCT国际专利申请，并向专利代理人提交了若干其他可申请专利的发现的知识产权证明。Diwan博士曾获得多项学术荣誉，包括在所有IIT的联合入学考试中获得全印度第9名。他拥有美国莱斯大学生化工程博士学位-1986年和印度理工学院（IIT）孟买化学工程学士学位-1980年。
Anil Diwan,has been President and the Chairman of the Board of Directors of the Company since consummation of the merger on June 1, 2005. Dr. Diwan simultaneously therewith and since its formation, has also served as the Chief Executive Officer and Director of AllExcel, Inc. (from 1995 to the present) and TheraCour Pharma, Inc. (from 2004 to the present) and is the original inventor of the technologies licensed to NanoViricides Inc., as well as the TheraCour polymeric micelle technologies and products based on them. Since 1992, he has researched and developed TheraCour nanomaterials. Dr. Diwan was one of the first scientists to propose the development of novel pendant polymers for drug delivery that led to an explosion of research in pharmacological applications of polymeric micelles. Dr. Diwan has won over 12 NIH SBIR grants. Dr. Diwan holds several issued patents, and two recent PCT international patent applications in various stages of prosecution in a number of countries, and also has several additional patentable discoveries. Dr. Diwan has held several scholastic distinctions, including an All-India 9th rank on the Joint Entrance Examination of all IIT's. He holds a Ph.D. in Biochemical Engineering from Rice University (1986) and B.S. in Chemical Engineering from Indian Institute of Technology (IIT) Bombay (1980).- Anil Diwan自2005年6月1日NanoViricides完成合并以来，一直担任NanoViricides总裁兼董事会主席，2019年2月担任执行主席。Diwan博士自1995年起担任AllExcel公司首席执行官兼董事，2004年至今担任TheraCour制药公司首席执行官，并且是NanoViricides公司许可使用的技术的原始发明人，以及基于它们的TheraCour聚合物胶束技术和产品。自1992年起，他开始研究和开发TheraCour纳米材料。Diwan博士是最早提出开发用于药物递送的新型悬挂式聚合物的科学家之一，这导致了聚合物胶束的药理应用研究的爆炸式增长。Anil已经获得了超过12项NIH SBIR资助。Diwan博士拥有若干已发布的专利，以及在若干国家处于不同起诉阶段的五项PCT国际专利申请，并向专利代理人提交了若干其他可申请专利的发现的知识产权证明。Diwan博士曾获得多项学术荣誉，包括在所有IIT的联合入学考试中获得全印度第9名。他拥有美国莱斯大学生化工程博士学位-1986年和印度理工学院（IIT）孟买化学工程学士学位-1980年。
- Anil Diwan,has been President and the Chairman of the Board of Directors of the Company since consummation of the merger on June 1, 2005. Dr. Diwan simultaneously therewith and since its formation, has also served as the Chief Executive Officer and Director of AllExcel, Inc. (from 1995 to the present) and TheraCour Pharma, Inc. (from 2004 to the present) and is the original inventor of the technologies licensed to NanoViricides Inc., as well as the TheraCour polymeric micelle technologies and products based on them. Since 1992, he has researched and developed TheraCour nanomaterials. Dr. Diwan was one of the first scientists to propose the development of novel pendant polymers for drug delivery that led to an explosion of research in pharmacological applications of polymeric micelles. Dr. Diwan has won over 12 NIH SBIR grants. Dr. Diwan holds several issued patents, and two recent PCT international patent applications in various stages of prosecution in a number of countries, and also has several additional patentable discoveries. Dr. Diwan has held several scholastic distinctions, including an All-India 9th rank on the Joint Entrance Examination of all IIT's. He holds a Ph.D. in Biochemical Engineering from Rice University (1986) and B.S. in Chemical Engineering from Indian Institute of Technology (IIT) Bombay (1980).
- Meeta Vyas
Meeta Vyas是一名公认的强有力的领导，她具有董事会层面的经验和在广泛的实体任高级执行官的成功业绩，包括上市公司，非创收实体及大型企业。她拥有超过二十五年在上市公司和非创收实体绩效和流程改进经验，领域设计从公司财务和运营到策略与管理。 她是第一个在美国上市公司 Signature Brands, Inc.，任首席执行官的印度女人，公司最著名的是 “Mr. Coffee”和“Health-O-Meter”品牌产品。作为首席执行官，代理首席运营官及公司的副董事长，她负责的重组计划的制定和实施，致使 Signature’s 恢复盈利和增长。后来，作为World-Wide Fund for Nature - India WWF-India 的首席执行官，随后作为 National Audubon Society （USA）副总裁，这两个都是非创收实体，她成功募集不受限制的资金，大大超过年度需求并且还设立了财务流程，以评测各种性能指标。在她的职业生涯早期，她负责General Electric （“GE”）非常成功的信息技术外包项目的设计战略并启动了实施计划。此外，在GE，她经营 GE Appliances’ Range Products 业务部，其营业额超过10亿美元，其中她的团队在不到两年的时间增加了一倍营业收入。在此之前，她任McKinsey 和 Company 管理顾问，她任职于化学品，工业和技术市场相关上市公司，主要侧重于增长战略，评估，并购后的整合，以及物流业务。她和 Anil Diwan结婚，丈夫是TheraCour Pharma, Inc. 的总裁和董事长，主要股东。她拥有 Columbia University’s Graduate School of Business金融学工商管理硕士学位和Massachusetts Institute of Technology化学工程学士学位。
Meeta Vyas,has served as the Company's Chief Financial Officer since May13, 2013. Ms.Vyas has over twenty-fiveyears of experience in performance and process improvement of both publicly listed companies and non-revenue producing entities, in areas ranging from Finance and Operations to Strategy and Management. Meeta holds the distinction of being the first Indian woman to be named CEO of a publicly listed U.S.corporation, Signature Brands,Inc., best known for "Mr.Coffee" and "Health-O-Meter" brand products. As CEO, acting COO and Vice Chairman of the Board of Signature Brands,Inc., she was responsible for the development and implementation of a turnaround plan, resulting in Signature's return to profitability and growth. Later, as the CEO of the World-Wide Fund for Nature - India (WWF-India) and then as a Vice President of the National Audubon Society (USA), both not-for-profit, non-revenue generating entities, Meeta successfully raised unrestricted funding that significantly exceeded annual requirements and also instituted financial processes to measure a variety of performance metrics. Earlier in her career, she was responsible for designing the strategy and initiating the implementation plan for the highly successful information technology outsourcing program at General Electric ("GE"). Also at GE, Ms.Vyas ran GE Appliances' Range Products business unit having revenues exceeding $1 Billion where her team doubled operating income in less than twoyears. Prior to that, as a management consultant with McKinsey and Company, she served publicly listed companies in chemicals, industrial, and technology markets, primarily focusing on growth strategies, valuations, post-merger integrations, and logistics operations. Ms.Vyas is married to Anil Diwan, the Company's President and Chairman and principal shareholder of TheraCour Pharma,Inc. Ms.Vyas holds a MBA in Finance from Columbia University's Graduate School of Business, and a SB in Chemical Engineering from the Massachusetts Institute of Technology.- Meeta Vyas是一名公认的强有力的领导，她具有董事会层面的经验和在广泛的实体任高级执行官的成功业绩，包括上市公司，非创收实体及大型企业。她拥有超过二十五年在上市公司和非创收实体绩效和流程改进经验，领域设计从公司财务和运营到策略与管理。 她是第一个在美国上市公司 Signature Brands, Inc.，任首席执行官的印度女人，公司最著名的是 “Mr. Coffee”和“Health-O-Meter”品牌产品。作为首席执行官，代理首席运营官及公司的副董事长，她负责的重组计划的制定和实施，致使 Signature’s 恢复盈利和增长。后来，作为World-Wide Fund for Nature - India WWF-India 的首席执行官，随后作为 National Audubon Society （USA）副总裁，这两个都是非创收实体，她成功募集不受限制的资金，大大超过年度需求并且还设立了财务流程，以评测各种性能指标。在她的职业生涯早期，她负责General Electric （“GE”）非常成功的信息技术外包项目的设计战略并启动了实施计划。此外，在GE，她经营 GE Appliances’ Range Products 业务部，其营业额超过10亿美元，其中她的团队在不到两年的时间增加了一倍营业收入。在此之前，她任McKinsey 和 Company 管理顾问，她任职于化学品，工业和技术市场相关上市公司，主要侧重于增长战略，评估，并购后的整合，以及物流业务。她和 Anil Diwan结婚，丈夫是TheraCour Pharma, Inc. 的总裁和董事长，主要股东。她拥有 Columbia University’s Graduate School of Business金融学工商管理硕士学位和Massachusetts Institute of Technology化学工程学士学位。
- Meeta Vyas,has served as the Company's Chief Financial Officer since May13, 2013. Ms.Vyas has over twenty-fiveyears of experience in performance and process improvement of both publicly listed companies and non-revenue producing entities, in areas ranging from Finance and Operations to Strategy and Management. Meeta holds the distinction of being the first Indian woman to be named CEO of a publicly listed U.S.corporation, Signature Brands,Inc., best known for "Mr.Coffee" and "Health-O-Meter" brand products. As CEO, acting COO and Vice Chairman of the Board of Signature Brands,Inc., she was responsible for the development and implementation of a turnaround plan, resulting in Signature's return to profitability and growth. Later, as the CEO of the World-Wide Fund for Nature - India (WWF-India) and then as a Vice President of the National Audubon Society (USA), both not-for-profit, non-revenue generating entities, Meeta successfully raised unrestricted funding that significantly exceeded annual requirements and also instituted financial processes to measure a variety of performance metrics. Earlier in her career, she was responsible for designing the strategy and initiating the implementation plan for the highly successful information technology outsourcing program at General Electric ("GE"). Also at GE, Ms.Vyas ran GE Appliances' Range Products business unit having revenues exceeding $1 Billion where her team doubled operating income in less than twoyears. Prior to that, as a management consultant with McKinsey and Company, she served publicly listed companies in chemicals, industrial, and technology markets, primarily focusing on growth strategies, valuations, post-merger integrations, and logistics operations. Ms.Vyas is married to Anil Diwan, the Company's President and Chairman and principal shareholder of TheraCour Pharma,Inc. Ms.Vyas holds a MBA in Finance from Columbia University's Graduate School of Business, and a SB in Chemical Engineering from the Massachusetts Institute of Technology.